Cocarnit

Use of a metabolic drug in the complex therapy of patients with open-angle glaucoma
Published in a journal «Ophthalmology. Eastern Europe» Vol 10 № 3’2020
Personalized study of the effectiveness of Cocarnit in the clinic of alcohol dependence at the stage of withdrawal syndrome
Clinical experience of using Cocarnite in the complex treatment of patients with ischemic heart disease and chronic heart failure
Published in Medical Gazette «Health of Ukraine 21st century» № 2(447) ’2019
The effectiveness of combination therapy using meloxicam (Loxidol) and Cocarnit in the treatment of patients with chronic diseases of the musculoskeletal system during an exacerbation
Published in a journal «Trauma» Vol 18 № 6 ’2017
A new complex of metabolic substances and vitamins in the treatment of eye burns and their consequences
Published in a journal «Ophthalmology. Eastern Europe» Vol 7 № 2 ’2017
Determination of the optimal scheme of administration of Cocarnite to rats with diabetic polyneuropathy using the tensoalgometric method
Published in the journal «Problems of regulation of physiological functions» № 2(23) ’2017
Comparative analysis of the effect of physiotherapy methods on pain syndrome in patients with dorsalgia at the outpatient-polyclinic stage of treatment
Published in a journal «Medical hydrology and rehabilitation» № 2’2013
Clinical and pathogenetic relationship of autonomic and myofascial dysfunction (assessment of the effectiveness of the drug Cocarnit)
Published in a journal «International neurological journal» № 1(55) ’2013
Dynamics of indicators of video laryngostroboscopy during complex treatment of patients with persistent functional dysphonias, which are accompanied by pronounced hypotonia of the vocal apparatus
Published in a journal «Journal of Ear, Nose and Throat Diseases» № 6’ 2012
Energy-dynamic correction of chronic heart failure in arterial hypertension of renal origin
Published in the journal «Arterial Hypertension» № 6(26) ’2012

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design